Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9277089 | EMC - Maladies Infectieuses | 2005 | 9 Pages |
Abstract
Ketolides are semi-synthetic derivatives of Erythromycin A. Telithromycin is the first introduced in clinical practice. It was developed specifically for the treatment of community-acquired respiratory tract infections, since it demonstrates bacteriological efficiency against common and atypical respiratory pathogens, as well as good diffusion in respiratory tissues. It maintains efficacy against erythromycin resistant Gram-positive cocci and seems to not induce MLSB resistance. Telithromycin is available currently, but the other agents of this therapeutic class are not marketed yet.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
N. Viget, L. Legout, S. Alfandari,